Nan Rothrock, Ph.D. Northwestern University May 22, 2012.
Asthma Physiology and Natural Support Options Catherine Oshin Nat 307 Module 11 Discuss the physiology of asthma. What natural support options are available?
csupharmacol.com Pharmacology Chapter 1.Introduction About Pharmacology Chapter 2.Pharmacokinetics What the body does to a drug Chapter 3.Pharmacodynamics.
Monika Kawohl Principal Statistical Programmer Accovion GmbH, Marburg, Germany New FDA Documents - Discussion of Implementation Considerations.
ADaM IG, May 2008 ADaM Implementation Guide: Its Almost Here. Are You Ready? Sandra Minjoe Principal Statistical Programmer Analyst Genentech, Inc.
1 Off-Label Use of Medications in Workers Compensation Matthew Foster, PharmD, BCPS PMSI Clinical Services.
Prosecutorial Perspective on Off- Label Promotion Virginia Gibson Assistant U.S. Attorney National Pharma AudioConference, October 26, 2004.
The Constitutional Convention May-September 1787 Goal: Amend the Articles of Confederation Ideas behind the Constitution: –The Enlightenment –3-part government.
Labeling claims for patient- reported outcomes (A regulatory perspective) FDA/Industry Workshop Washington, DC September 16, 2005 Lisa A. Kammerman, Ph.D.
Surrogate Markers and its role in the Drug Development Process Aloka G. Chakravarty, Ph.D. Director, Biologics Therapeutics Statistical Staff [email protected].
1 Revising FDAs Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests FDA/Industry Statistics Workshop September 28-29, 2006.
A History of Stats at the FDA Mary A. Foulkes, Ph.D. U.S. Food And Drug Administration Office of Biostatistics and Epidemiology Center for Biologics Evaluation.
